CD8+ T cell activation in endometrial cancer: prognostic implications and potential for personalized therapy
This study provides a predictive tool for endometrial cancer. The classification based on the status of CD8+ T cells can distinguish the prognosis and treatment response, highlighting the potential of this model in personalized treatment.
Authors
- Qian Xiong (ORCID: https://orcid.org/0000-0002-0547-039X)
- Wei Zhang (ORCID: https://orcid.org/0000-0002-0279-951X)
- Haotong Guan
- Yanyan Liu (ORCID: https://orcid.org/0000-0001-9707-2083)
- Jun Xiong (ORCID: https://orcid.org/0000-0003-2598-0706)
Institutions
- Wuhan University (CN)
- Zhongnan Hospital of Wuhan University (CN)
- Wuhan Union Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-28
- DOI
- https://doi.org/10.3389/fimmu.2025.1542669
- Citations
- 2
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.11